𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Insulin-like Growth Factor 2 cDNA Cloning and Ontogeny of Gene Expression in the Liver of the Marsupial Brushtail Possum (Trichosurus vulpecula)

✍ Scribed by M.C. Saunders; R.T. Gemmell; J.D. Curlewis

Book ID
112246932
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
190 KB
Volume
121
Category
Article
ISSN
0016-6480

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Loss of imprinting and abnormal expressi
Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer
✍ Qing-Song Zuo; Ronglin Yan; Dian-Xu Feng; Ronghua Zhao; Chao Chen; Yi-Ming Jiang πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 231 KB πŸ‘ 1 views

## Abstract This study examined the frequency of loss of imprinting (LOI) and expression of the insulin‐like growth factor 2 (__IGF2__) gene, and their relationship to selected clinical and pathological factors, in a well defined series of 90 Chinese patients with gastric cancer (GC) and 90 matched

Expression of the wilms' tumor gene WT1
Expression of the wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression
✍ Anthonie W. Langerak; Kathleen A. Williamson; Kiyoshi Miyagawa; Anne Hagemeijer; πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 929 KB

Mutations in the WTI tumor suppressor gene are known t o contribute t o the development of Wilms' tumor (WT) and associated gonadal abnormalities. WTI is expressed principally in the fetal kidney, developing gonads, and spleen and also in the mesothelium, which lines the coelomic cavities. These tis

Effect of budesonide on the methylation
Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors
✍ Lianhui Tao; Yingzhe Li; Wei Wang; Paula M. Kramer; William T. Gunning; Ronald A πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 357 KB πŸ‘ 1 views

## Abstract The use of surrogate end‐point biomarkers could help in the development of chemopreventive agents. To define potential surrogate end‐point biomarkers, the ability of budesonide to decrease mRNA expression of the insulin‐like growth factor‐2 (__Igf‐II__) and c‐__myc__ genes and to cause